Assessing the Benefits of Robotic and Laparoscopic Surgery for Mid and Low Rectal Cancer in Patients: The Charlson Comorbidity Index (CCI)

NCT06396845 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 505

Last updated 2024-05-02

No results posted yet for this study

Summary

This retrospective study collected participants who underwent robotic or laparoscopic anterior resection for rectal cancer at the North People's Hospital in Jiangsu from January 2019 to January 2023.

Conditions

  • Robotic
  • Laparoscopic
  • Anterior Resection for Rectal Cancer

Interventions

PROCEDURE

robotic surgery

robotic surgery

PROCEDURE

laparoscopic surgery

laparoscopic surgery

Sponsors & Collaborators

  • Daorong Wang

    lead OTHER

Eligibility

Min Age
55 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2022-01-01
Completion
2024-01-03

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06396845 on ClinicalTrials.gov